EMIEL HENDRIKS is owner of Restracon BV, an independent Consultancy enterprise dedicated to the development of vaccines for veterinary and human use.

Emiel has over 40 years experience in product development and regulatory approval of vaccines. The development involves deep knowledge of manufacturing, quality control, pre-clinical and clinical programs  and overall project management. Regulatory approval involves the preparation of risk assessments, expert opinions as well as the compilation and submission of the regulatory dossiers via dedicated systems (Europe). Together with a team of experts Restracon BV can also provide dedicated expertise (like statistical support) on the various aspects of product development.